When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SNY - Filgotinib worth as much as $6/share to Gilead - Leerink
Sanofi
Leerink's Geoffrey Porges likes the upside of arthritis med filgotinib for Gilead Sciences (NASDAQ:GILD), projecting a $5 - 6/share potential bump in value. He says the JAK1 inhibitor has an 80% (unclear how he arrived at this specific figure) chance of reaching $3.7B in peak sales (how far in the future is also unclear) considering its "best in class" efficacy.
More news on: Gilead Sciences, Inc., Galapagos NV, AbbVie Inc., Healthcare stocks news, Stocks on the move,